CR (Crane Company) Stock Analysis - Hedge Fund Holdings
Crane Company (CR) is a publicly traded Industrials sector company. As of May 21, 2026, CR trades at $173.41 with a market cap of $9.86B and a P/E ratio of 27.06. CR moved +3.62% today. Year to date, CR is -10.78%; over the trailing twelve months it is -1.03%. Its 52-week range spans $127.04 to $214.31. Analyst consensus is strong buy with an average price target of $225.00. Rallies surfaces CR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CR stock?
Hedge funds tracked by Rallies that own CR include Bridgewater Associates, Panagora Asset, Pinebridge Investments, and Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Crane Company.
CR Key Metrics
Key financial metrics for CR
Metric
Value
Price
$173.41
Market Cap
$9.86B
P/E Ratio
27.06
EPS
$6.38
Dividend Yield
0.26%
52-Week High
$214.31
52-Week Low
$127.04
Volume
0
Avg Volume
0
Revenue (TTM)
$2.31B
Net Income
$366.60M
Gross Margin
42.20%
Top Hedge Funds Holding CR
Bridgewater Associates holds 103.44K shares of CR, changed +399.45% as of Mar 31, 2026.
Panagora Asset holds 97.05K shares of CR, changed +6230.85% as of Mar 31, 2026.
Pinebridge Investments holds 4.58K shares of CR, changed -70.82% as of Mar 31, 2025.
Maverick Capital holds 1.85K shares of CR, changed +0.00% as of Dec 31, 2023.
Hedge funds tracked by Rallies that own CR include Bridgewater Associates, Panagora Asset, Pinebridge Investments, and Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Crane Company.
Does Rallies show 13F holders for CR?
Yes. Rallies tracks hedge fund and 13F ownership data for CR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CR. It does not provide personalized investment advice.